Pharma

Your Article Summary

See Latest Articles

Taro Provides Preliminary First Half 2009 Financial Results
Taro Pharmaceuticals USA, 08/11/09

Taro Pharmaceutical Industries Ltd. provided information on its financial performance for the first half of 2009. For the six months ended June 30, 2009, Taro estimates net sales of $181.7 million compared to $166.2 million in the same period of the previous year, a 9% increase. Gross profit for the first half of 2009 was $104.4 million, or 57% of net sales, compared to a gross profit of $91.5 million, or 55% of net sales for the same period in 2008, an increase of 14%.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09

Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

 See all of Financial Reports